Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled …

A Weisman, JW Bai, M Cardinez, CK Kramer… - The lancet Diabetes & …, 2017 - thelancet.com
Background Closed-loop artificial pancreas systems have been in development for several
years, including assessment in numerous varied outpatient clinical trials. We aimed to …

Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis

E Bekiari, K Kitsios, H Thabit, M Tauschmann… - bmj, 2018 - bmj.com
Objective To evaluate the efficacy and safety of artificial pancreas treatment in non-pregnant
outpatients with type 1 diabetes. Design Systematic review and meta-analysis of …

[HTML][HTML] Open-source automated insulin delivery in type 1 diabetes

MJ Burnside, DM Lewis, HR Crocket… - … England Journal of …, 2022 - Mass Medical Soc
Background Open-source automated insulin delivery (AID) systems are used by many
patients with type 1 diabetes. Data are needed on the efficacy and safety of an open-source …

Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial

M Tauschmann, H Thabit, L Bally, JM Allen, S Hartnell… - The Lancet, 2018 - thelancet.com
Background The achievement of glycaemic control remains challenging for patients with
type 1 diabetes. We assessed the effectiveness of day-and-night hybrid closed-loop insulin …

Home use of an artificial beta cell in type 1 diabetes

H Thabit, M Tauschmann, JM Allen… - … England Journal of …, 2015 - Mass Medical Soc
Background The feasibility, safety, and efficacy of prolonged use of an artificial beta cell
(closed-loop insulin-delivery system) in the home setting have not been established …

[PDF][PDF] ISPAD clinical practice consensus guidelines 2018: diabetes technologies

JL Sherr, M Tauschmann, T Battelino, M de Bock… - Pediatr Diabetes, 2018 - bnsde.org
ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies Page 1 ISPAD
CLINICAL PRACTICE CONSENSUS GUIDELINES ISPAD Clinical Practice Consensus …

A review of personalized blood glucose prediction strategies for T1DM patients

S Oviedo, J Vehí, R Calm… - International journal for …, 2017 - Wiley Online Library
This paper presents a methodological review of models for predicting blood glucose (BG)
concentration, risks and BG events. The surveyed models are classified into three …

Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial

FH El-Khatib, C Balliro, MA Hillard, KL Magyar… - The Lancet, 2017 - thelancet.com
Background The safety and effectiveness of a continuous, day-and-night automated
glycaemic control system using insulin and glucagon has not been shown in a free-living …

[HTML][HTML] Current advances of artificial pancreas systems: a comprehensive review of the clinical evidence

SJ Moon, I Jung, CY Park - Diabetes & Metabolism Journal, 2021 - synapse.koreamed.org
Abstract Since Banting and Best isolated insulin in the 1920s, dramatic progress has been
made in the treatment of type 1 diabetes mellitus (T1DM). However, dose titration and timely …

Coming of age: the artificial pancreas for type 1 diabetes

H Thabit, R Hovorka - Diabetologia, 2016 - Springer
The artificial pancreas (closed-loop system) addresses the unmet clinical need for improved
glucose control whilst reducing the burden of diabetes self-care in type 1 diabetes. Glucose …